IADR Abstract Archives
Clinical Features and Radiotherapy in Head and Neck Cancer Patients
Objectives: The aim of the study was to investigate the clinical characteristics and radiation therapy in head and neck cancer patients.
Methods: The study was performed in 52 head and neck cancer patients at Can Tho Oncology Hospital from January to May 2020. Information collected included age, gender, clinical symptoms, diagnosis, TNM classification, radiotherapy. Data were analyzed using SPSS 22.0 software.
Results: The majority of the 52 patients were male (n=40; 76.9%). The mean age was 57.77 years, with a standard deviation of 13.45 years (range, 20-90 years). The majority of the patients were diagnosed with pharynx carcinoma (n=34; 65.5%), followed by 13 (25.0%) patients with oral cancer. A total of 3 patients (3.8%) had carcinoma of larynx and nasal cavity. T4 tumors accounted for the highest proportion (40.4%), T2 and T3 were equal (28.8%), the lowest was T1 (1.9%). The most common nodal status was N2 (44.2%), followed by N0 (40.4%). The majority of the patients had local metastases (n= 31; 59.6%). Patients in stage IV accounted for the highest proportion (55.8%), stage II was the least (13.5%), there was no stage I. The average of total radiation dose was 67.23 ± 9.515 (Gy). The highest radiation dose was 70 Gy accounting for 88.5% (46 cases), the lowest was 30 Gy accounting for 5.8% (3 cases). Chemoradiation accounted for the highest proportion (73.1%), surgery combined with radiation (3.8%) and surgery combined with chemoradiation (3.8%) accounted for the lowest proportion.
Conclusions: Head and neck cancer happened in patients 40-60 years old, males more than females. More than 90% of head and neck cancers was pharynx carcinoma with local metastases. Chemoradiation was the most popular therapy for treatment in head and neck cancer patients with T4, N2 and stage IV.
Methods: The study was performed in 52 head and neck cancer patients at Can Tho Oncology Hospital from January to May 2020. Information collected included age, gender, clinical symptoms, diagnosis, TNM classification, radiotherapy. Data were analyzed using SPSS 22.0 software.
Results: The majority of the 52 patients were male (n=40; 76.9%). The mean age was 57.77 years, with a standard deviation of 13.45 years (range, 20-90 years). The majority of the patients were diagnosed with pharynx carcinoma (n=34; 65.5%), followed by 13 (25.0%) patients with oral cancer. A total of 3 patients (3.8%) had carcinoma of larynx and nasal cavity. T4 tumors accounted for the highest proportion (40.4%), T2 and T3 were equal (28.8%), the lowest was T1 (1.9%). The most common nodal status was N2 (44.2%), followed by N0 (40.4%). The majority of the patients had local metastases (n= 31; 59.6%). Patients in stage IV accounted for the highest proportion (55.8%), stage II was the least (13.5%), there was no stage I. The average of total radiation dose was 67.23 ± 9.515 (Gy). The highest radiation dose was 70 Gy accounting for 88.5% (46 cases), the lowest was 30 Gy accounting for 5.8% (3 cases). Chemoradiation accounted for the highest proportion (73.1%), surgery combined with radiation (3.8%) and surgery combined with chemoradiation (3.8%) accounted for the lowest proportion.
Conclusions: Head and neck cancer happened in patients 40-60 years old, males more than females. More than 90% of head and neck cancers was pharynx carcinoma with local metastases. Chemoradiation was the most popular therapy for treatment in head and neck cancer patients with T4, N2 and stage IV.